FastBack Bio
PrivateCompany Overview
FastBack Bio is a biotechnology company with a novel CAR-T platform to develop T cell-based therapeutics and gene therapies to cure cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
CAR-T therapysolid tumor therapycell therapycell and gene therapyCGTco-stimulatory domainT-cell exhaustionM83 domainimmunotherapybiotech licensingoncologypreclinical biotechdrug developmentcell therapy manufacturingrenal cell carcinoma
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FastBack Bio Comparables
Compare FastBack Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inceptor Bio | 86% | |
| AffyImmune Therapeutics | 77% | |
| Roche Holding | 70% | |
FastBack Bio Funding Rounds
Historical fundraising activity
FastBack Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FastBack Bio's valuation, stock price, and market status.
See something wrong or outdated?